Phospho-ATF2 (T73) Antibody

What is ATF2 and what is the significance of its phosphorylation at Thr73?

ATF2 (Activating Transcription Factor 2) is a member of the ATF/CREB family of leucine zipper proteins that functions as a transcriptional activator. It binds to both AP-1 and CRE DNA response elements and regulates the transcription of various genes involved in anti-apoptosis, cell growth, and DNA damage response . Phosphorylation at Thr73 is one of several critical post-translational modifications that activates ATF2's transcriptional activity . This specific phosphorylation is part of the regulatory mechanism that controls ATF2 function in response to cellular stress and various signaling pathways.

How does Phospho-ATF2 (T73) antibody differ from other ATF2 phospho-antibodies?

Phospho-ATF2 (T73) antibody specifically detects endogenous levels of ATF2 protein only when phosphorylated at threonine 73 . This distinguishes it from other phospho-specific antibodies such as those targeting phosphorylation at Thr71 or dual phosphorylation sites like T71+T53 . The specificity is achieved through careful antibody production techniques, including affinity purification using epitope-specific immunogen derived from the human ATF2 around the phosphorylation site of Thr73 at the amino acid range 40-89 . This high specificity makes the antibody valuable for distinguishing between different phosphorylation states of ATF2 in experimental settings.

What are the common applications for Phospho-ATF2 (T73) antibody in research?

Phospho-ATF2 (T73) antibody is suitable for various research applications including:

• Western Blot (WB): Used at dilutions of 1:500-1:2000

• Immunohistochemistry (IHC): Used at dilutions of 1:100-1:300

• Immunofluorescence (IF): Used at dilutions of 1:50-200

• Immunoprecipitation (IP): Using 2-5 μg per mg of lysate

• ELISA: Used at dilutions up to 1:20000

These applications allow researchers to detect and quantify phosphorylated ATF2 at Thr73 in various sample types and experimental contexts, providing insights into ATF2 activation status under different conditions.

What are the recommended positive controls for validating Phospho-ATF2 (T73) antibody function?

While the search results don't specifically mention positive controls for Phospho-ATF2 (T73), similar phospho-ATF2 antibodies can be validated using anisomycin-treated cell lines. For instance, NIH3T3 cells or Jurkat cells treated with 10 μg/mL anisomycin for 60 minutes are recommended as positive controls for phospho-ATF2 (Thr71) antibodies . For Phospho-ATF2 (T73) validation, researchers should consider similar stress induction protocols, as anisomycin activates both JNK and p38 MAPK pathways which are known to phosphorylate ATF2 . Cell lines known to express ATF2, such as A549 cells, can also be considered for validation experiments after appropriate stress induction .

How should samples be prepared to preserve ATF2 phosphorylation for antibody detection?

Preserving phosphorylation status during sample preparation is critical for accurate detection with phospho-specific antibodies. Researchers should:

• Include phosphatase inhibitors in all lysis and extraction buffers

• Keep samples cold throughout processing

• Use rapid protein extraction protocols to minimize dephosphorylation

• Consider using phosphatase inhibitors like sodium orthovanadate, sodium fluoride, and β-glycerophosphate

• For tissue samples, consider rapid fixation methods to preserve phosphorylation status

When working with cell culture models, stimulation with appropriate activators of JNK and p38 MAPK pathways, such as anisomycin, can increase phosphorylation signal . For immunohistochemistry or immunofluorescence, proper fixation protocols that preserve phospho-epitopes should be employed.

What is the optimal storage and handling procedure for maintaining Phospho-ATF2 (T73) antibody activity?

According to the product information, Phospho-ATF2 (T73) antibody should be stored at -20°C for up to 1 year from the date of receipt . It's important to avoid repeated freeze-thaw cycles as these can diminish antibody activity. The antibody is typically formulated as a liquid in PBS containing 50% Glycerol, 0.5% BSA, and 0.02% Sodium Azide . For working solutions, store at 4°C for short-term use (1-2 weeks) and prepare fresh dilutions for each experiment to ensure consistent results. Always centrifuge the antibody briefly before opening the vial to ensure all liquid is at the bottom of the tube.

How can Phospho-ATF2 (T73) antibody be used to investigate the ATF2 phosphoswitch mechanism?

The ATF2 "phosphoswitch" refers to the complex regulatory mechanism where phosphorylation at specific residues controls ATF2 activity. Researchers can use Phospho-ATF2 (T73) antibody in combination with other phospho-specific antibodies to investigate this mechanism. The phosphoswitch involves phosphorylation at multiple sites including the 69-TPTP-72 region .

A comprehensive experimental approach would include:

• Comparative phosphorylation analysis using antibodies specific for different phosphorylation sites (T53, T71, T73)

• Time-course experiments following stimulus application to track sequential phosphorylation events

• Co-immunoprecipitation studies to identify interacting proteins affected by T73 phosphorylation

• Mutagenesis studies replacing T73 with alanine (phospho-null) or glutamic acid (phospho-mimetic)

• Analysis of transcriptional activity using reporter gene assays in cells expressing wild-type versus mutant ATF2

Research has shown that a Zn-finger + D-motif module (amino acids 19-58) is critical for JNK binding and subsequent phosphorylation of the 69-TPTP-72 target site . The Phospho-ATF2 (T73) antibody can help distinguish between JNK and p38 MAPK-mediated phosphorylation events in this complex regulatory system.

What are the methodological approaches for studying cross-talk between JNK and p38 MAPK pathways in ATF2 phosphorylation?

JNK and p38 MAPK pathways both contribute to ATF2 phosphorylation but have distinct binding regions and regulatory mechanisms . To study this cross-talk, researchers can:

• Use specific inhibitors for each pathway (e.g., JNK-IN-8 for JNK inhibition) while monitoring phosphorylation at T73 using the Phospho-ATF2 (T73) antibody

• Employ the NanoBit protein-protein interaction (PPI) assay to monitor binding of both p38 and JNK to ATF2 under various conditions

• Perform sequential immunoprecipitation experiments to isolate complexes containing ATF2 with either JNK or p38

• Analyze phosphorylation patterns after mutations in specific binding regions:

  • K48E mutation affects the Zn-finger + D-motif module critical for JNK binding

  • MUT4 (92-FENEF-96 → 92-AENEA-96) affects p38 binding

• Conduct in vitro kinase assays with purified components to determine direct phosphorylation patterns

Research shows that while JNK-ATF2 binding remains constant regardless of JNK activation status, p38-ATF2 binding increases when p38 is activated . This differential regulation provides a useful experimental framework for studying pathway cross-talk.

How can Phospho-ATF2 (T73) antibody be used in conjunction with site-directed mutagenesis to understand ATF2 function?

Site-directed mutagenesis combined with Phospho-ATF2 (T73) antibody detection provides powerful insights into ATF2 function. A comprehensive experimental approach includes:

• Generate ATF2 variants with mutations at:

  • The phosphorylation site itself (T73A to prevent phosphorylation)

  • Critical residues in binding regions for JNK (K48E) or p38 (MUT4)

  • Adjacent phosphorylation sites (T69, T71) to study sequential phosphorylation

• Express these mutants in cellular systems where endogenous ATF2 has been knocked out

• Use the Phospho-ATF2 (T73) antibody to:

  • Confirm loss of T73 phosphorylation in T73A mutants

  • Assess how mutations in binding regions affect T73 phosphorylation

  • Determine how modifications at other sites affect T73 phosphorylation status

• Correlate phosphorylation status with:

  • Transcriptional activity using reporter gene assays

  • Nuclear localization using immunofluorescence

  • Protein-protein interactions using co-immunoprecipitation

  • Chromatin binding using ChIP assays

  • Cell phenotypes like proliferation, apoptosis, or stress response

This approach has revealed that the Zn-finger + D-motif module and the FENEF motif are indispensable for p38-mediated TAD phosphorylation, while JNK-mediated phosphorylation requires the Zn-finger + D-motif but is unaffected by FENEF motif mutations .

What are common sources of false positives/negatives when using Phospho-ATF2 (T73) antibody, and how can they be mitigated?

Several factors can contribute to false results when using phospho-specific antibodies:

Sources of false positives:

• Cross-reactivity with similar phosphorylation motifs on other proteins

• Non-specific binding due to excessive antibody concentration

• Inadequate blocking or washing steps

• Sample overloading causing non-specific background

Sources of false negatives:

• Rapid dephosphorylation during sample preparation

• Epitope masking due to protein-protein interactions

• Insufficient incubation time or antibody concentration

• Inappropriate detection method sensitivity

Mitigation strategies:

• Always include positive and negative controls in each experiment

• Use phosphatase inhibitors during sample preparation

• Validate antibody specificity using phosphatase treatment of a portion of your sample

• Optimize antibody concentration through titration experiments

• Consider using peptide competition assays to confirm specificity

• For Western blots, verify signal specificity by molecular weight

• In microscopy applications, include phospho-null mutants as controls

High-quality phospho-ATF2 antibodies are often negatively preadsorbed using non-phosphopeptides to remove antibody that is reactive with non-phosphorylated ATF2 , enhancing their specificity.

How should researchers interpret discrepancies between phosphorylation detected at different ATF2 sites (T53, T71, and T73)?

Discrepancies in phosphorylation patterns across different ATF2 sites often reflect the complex regulation of this transcription factor. When interpreting such data:

• Consider the temporal dynamics of phosphorylation:

  • Some sites may be phosphorylated sequentially rather than simultaneously

  • Time-course experiments can reveal whether certain sites are phosphorylated earlier than others

• Evaluate pathway-specific activation:

  • T71 is phosphorylated by multiple kinases including JNK, ERK1/2, and p38 MAPK

  • Different stimuli may preferentially activate specific kinases, leading to site-specific phosphorylation patterns

• Examine the functional consequences:

  • Phosphorylation at certain sites (like T69 and T71) enhances ATF2 transcriptional activity

  • Some phosphorylation events may affect protein stability rather than activity

  • Certain phosphorylation patterns may direct ATF2 to specific gene targets

• Assess cellular compartment-specific effects:

  • Nuclear versus cytoplasmic phosphorylated ATF2 may have different functions

  • Some phosphorylation events may affect subcellular localization

• Consider context dependency:

  • Cell type-specific effects may alter phosphorylation patterns

  • Different stressors may induce unique phosphorylation signatures

The relationship between these sites can be complex, as some phosphorylation events enhance or inhibit others. For example, research has shown that Ser90 phosphorylation by JNK negatively affects pp-p38:ATF2-TAD binding , illustrating how phosphorylation at one site can influence interactions at other sites.

What are the best methods for quantifying changes in ATF2 phosphorylation at T73 across experimental conditions?

Accurate quantification of phosphorylation changes is critical for understanding ATF2 regulation. Several methodological approaches are recommended:

Western Blot Quantification:

• Always normalize phospho-ATF2 (T73) signal to total ATF2 levels

• Use internal loading controls (β-actin, GAPDH) to ensure equal protein loading

• Employ quantitative software (ImageJ, Image Lab) to measure band intensity

• Present data as the ratio of phospho-ATF2 to total ATF2

• Perform at least three biological replicates for statistical validation

ELISA-Based Quantification:

• Use sandwich ELISA with capture antibody against total ATF2 and detection antibody against phospho-T73

• Develop standard curves using known quantities of phosphorylated recombinant protein

• The Phospho-ATF2 (T73) antibody can be used at dilutions up to 1:20000 for ELISA applications

Flow Cytometry:

• Fix and permeabilize cells to allow antibody access to intracellular phospho-epitopes

• Stain with fluorochrome-conjugated Phospho-ATF2 (T73) antibody

• Measure mean fluorescence intensity as a quantitative metric of phosphorylation

• Compare with total ATF2 staining in parallel samples

Immunofluorescence Quantification:

• Use standardized image acquisition parameters across all samples

• Quantify nuclear versus cytoplasmic signal intensity

• Normalize to total ATF2 staining in parallel samples

• The recommended dilution for immunofluorescence is 1:50-200

For all methods, inclusion of appropriate controls is essential, including:

• Unstimulated cells (negative control)

• Cells treated with known activators like anisomycin (positive control)

• Phosphatase-treated samples to confirm signal specificity

How can Phospho-ATF2 (T73) antibody be used to study the differential nuclear and cytoplasmic functions of ATF2?

ATF2 exhibits distinct functions in nuclear and cytoplasmic compartments. In the nucleus, it contributes to global transcription and DNA damage response, while in the cytoplasm, it can interact with mitochondrial proteins to affect cell death . Phospho-ATF2 (T73) antibody can be instrumental in studying these compartment-specific functions:

Methodological Approach:

• Subcellular Fractionation:

  • Separate nuclear and cytoplasmic fractions

  • Analyze phosphorylation status in each fraction by Western blot

  • Compare with total ATF2 distribution

• Immunofluorescence Co-localization:

  • Use Phospho-ATF2 (T73) antibody with compartment-specific markers

  • Quantify co-localization with nuclear (DAPI) versus mitochondrial (MitoTracker) markers

  • Track changes in localization following various cellular stresses

• Proximity Ligation Assay (PLA):

  • Identify in situ protein interactions specific to phosphorylated ATF2

  • Compare interaction patterns between nuclear factors (transcriptional machinery) and cytoplasmic partners (mitochondrial proteins like HK1 and VDAC1)

• ChIP-seq with Phospho-Specific Antibodies:

  • Map genomic binding sites specific to phosphorylated ATF2

  • Compare with total ATF2 binding patterns

  • Identify genes specifically regulated by phosphorylated ATF2

This multi-modal approach can reveal how T73 phosphorylation affects ATF2's subcellular distribution and function across different cellular compartments.

What is the relationship between ATF2 phosphorylation and its histone acetyltransferase (HAT) activity?

ATF2 exhibits histone acetyltransferase (HAT) activity that specifically acetylates histones H2B and H4 in vitro . The relationship between phosphorylation and this enzymatic activity represents an important area of research:

Experimental Approaches:

• In Vitro HAT Assays:

  • Purify wild-type and phospho-mimetic ATF2 (T73E) variants

  • Compare HAT activity using core histones or nucleosomes as substrates

  • Quantify acetylation via Western blot with acetyl-specific antibodies or MS-based approaches

• Cellular HAT Activity Correlation:

  • Induce ATF2 phosphorylation via stress stimuli

  • Measure global histone acetylation changes by Western blot

  • Perform ChIP-seq with antibodies against both phospho-ATF2 and acetylated histones

  • Analyze correlation between ATF2 binding, phosphorylation status, and histone acetylation patterns

• Mutational Analysis:

  • Generate phospho-null (T73A) and phospho-mimetic (T73E) ATF2 variants

  • Compare their HAT activity and binding to chromatin

  • Assess impact on transcriptional output of target genes

Research has shown that phosphorylation at Thr-69 or Thr-71 enhances acetylation of histones H2B and H4 , suggesting that phosphorylation status directly influences ATF2's HAT activity. The Phospho-ATF2 (T73) antibody would be valuable in extending these studies to understand the specific contribution of T73 phosphorylation to this regulatory mechanism.

How can Phospho-ATF2 (T73) antibody contribute to understanding ATF2's role in the DNA damage response?

ATF2 plays an important role in DNA damage response and is involved in ionizing radiation (IR)-induced S phase checkpoint control . Phospho-ATF2 (T73) antibody can be used to investigate these functions:

Research Strategies:

• DNA Damage Response Kinetics:

  • Track T73 phosphorylation kinetics following various DNA damaging agents

  • Compare with ATM/ATR activation and other DNA damage markers

  • Use specific inhibitors of ATM/ATR pathways to determine their contribution to T73 phosphorylation

• Recruitment to DNA Damage Sites:

  • Perform chromatin immunoprecipitation (ChIP) with Phospho-ATF2 (T73) antibody following DNA damage

  • Use immunofluorescence to visualize co-localization with γH2AX foci

  • Employ proximity ligation assays to detect interactions with other DNA repair factors

• Functional Studies:

  • Assess how T73 phosphorylation affects recruitment of the MRN complex to IR-induced foci

  • Measure S-phase checkpoint activation in cells expressing wild-type versus T73A mutant ATF2

  • Evaluate DNA repair efficiency and cell survival following genotoxic stress

• Integration with Other Phosphorylation Events:

  • Compare T73 phosphorylation with ATM-mediated phosphorylation at Ser-490 and Ser-498

  • Determine hierarchical relationships between different phosphorylation events

  • Identify pathway-specific patterns of phosphorylation in response to different types of DNA damage

The phosphorylated form of ATF2 (mediated by ATM) plays a role in the DNA damage response and is involved in the recruitment of the MRN complex into IR-induced foci . Understanding how T73 phosphorylation contributes to this process would provide valuable insights into ATF2's function in maintaining genomic integrity.